Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million on February 20, 2024. The transaction is expected to complete by the end of February 2024 and is subject fulfilment of certain conditions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,516 INR | +0.02% | -0.32% | +20.22% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.22% | 43.57B | |
+20.70% | 22.7B | |
+15.08% | 14.32B | |
+11.71% | 13.42B | |
+44.95% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.51B | |
-3.58% | 4.76B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million.